A slight positive news and i think we will be back on track, even now you can see the buyers side is more than sellers, what that means is people are holding off their shares for a good return which looks likely 26 buyers 13 sellers (ratio 2:1). Agree PI-88's efficacy was disappointing but the drug is still safe and 40% of patient data is still pending. Also a review by bioclinica is pending this month or early next month which can improve things for Progen. Apart from all this the earnings report is expected to be out on 25th August so keep an eye on this one considering they have improved every year since 2009.
PGL Price at posting:
22.5¢ Sentiment: Hold Disclosure: Held
